(Press-News.org) Ann & Robert H. Lurie Children’s Hospital of Chicago is the first in Illinois to receive designation as a NORD Rare Disease Center of Excellence, becoming one of 40 U.S. academic medical centers selected to be a part of the first-of-it-kind national network of U.S. medical institutions dedicated to diagnosing, treating, and researching all rare diseases. The network is led by the National Organization for Rare Disorders (NORD) and is designed to foster knowledge sharing between rare disease experts across the country to help meet the unmet needs of more than 25 million Americans living with a rare disease.
Unlike other more common serious diseases like cancer and heart disease, people living with rare diseases face many challenges in finding a diagnosis and accessing quality clinical care. Because patient numbers battling a specific rare disease are so small (fewer than 200,000), physician expertise and research and development funds are sorely lacking. As a result, 95 percent of the more than 7,000 different rare diseases are without treatments.
“Lurie Children’s is excited to join the NORD network in our pursuit to optimize clinical outcomes and provide comprehensive lifelong care to patients with rare diseases through our partnership with Northwestern Medicine,” said Carlos Prada, MD, Division Head of Genetics, Genomics and Metabolism at Lurie Children’s and Director of the NORD Rare Diseases Center of Excellence. “We know it takes more than medicine to care for children with rare diseases. With compassion and understanding, we help patients access advanced diagnostics and multidisciplinary expertise, as well as offer opportunities to receive the most cutting-edge treatments through participation in clinical trials. We have one of the largest clinical trial units in the country for genetic and rare diseases.”
Dr. Prada is Chair of the Genomics Network and Medical Director of the RARE (Reassess, Analyze, Research, Empower) program at Lurie Children’s, which is a medical home for individuals with a suspected genetic diagnosis despite exhaustive non-diagnostic testing. He also is the Translational Research Director at Lurie Children’s and holds the Valerie and George D. Kennedy Research Professorship in Human Molecular Genetics. His leadership team for the NORD Rare Disease Center of Excellence includes Co-Directors Elizabeth McNally, MD, PhD (Northwestern University), Meredith Harris, MD (Lurie Children’s) and Allison Weisman, CGC (Lurie Children’s). Dr. McNally is an internationally recognized cardiovascular geneticist and Director for the Center for Genetic Medicine at Northwestern. Dr. Harris is a nephrologist at Lurie Children’s with interest in congenital anomalies of the urinary tract. Ms. Weisman is a genetic counselor with expertise in neurofibromatosis, disorders of sex development, fertility preservation, and leader in transitioning from pediatrics to adult care.
NORD has designated qualified world-class academic clinical centers like Lurie Children’s across the U.S. to improve rare disease patient care by connecting rare disease patients to appropriate specialists regardless of disease or geography. These Centers provide a much-needed national infrastructure to help accelerate advancements in rare disease diagnosis, treatment, and research.
Each center was selected by NORD in a competitive application process requiring evidence of staffing with experts across multiple specialties to meet the needs of rare disease patients and significant contributions to rare disease patient education, physician training, and research.
The NORD Rare Disease Centers of Excellence program is formulated to achieve better outcomes for all members of the rare disease community. This collaborative partnership strives to push the rare disease field forward by establishing and implementing new standards of care and innovating around new treatments, therapies, and research.
“Right now, far too many rare diseases are without an established standard of care. The Rare Disease Centers for Excellence Program will help set that standard – for patients, clinicians, and medical centers alike,” said Ed Neilan, Chief Scientific and Medical Officer of NORD. “We are proud to announce Lurie Children’s as a NORD Rare Disease Center of Excellence and look forward to their many further contributions as we collectively seek to improve health equity, care, and research to support all individuals with rare diseases.”
For more information about the NORD Rare Disease Centers of Excellence Program and the full list of Rare Disease Centers of Excellence, visit https://rarediseases.org/.
Rare Disease Facts and Impact:
It’s estimated that 25 - 30 million Americans have a rare disease.
(Source: https://ncats.nih.gov/files/NCATS_RareDiseasesFactSheet.pdf)
Half of individuals with a rare disease are children, and of those one in three will die before their fifth birthday.
(Source: https://ncats.nih.gov/files/NCATS_RareDiseasesFactSheet.pdf and https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185816/)
Diagnosis can take five years or more and overall medical costs are three to five times higher than non-rare diseases.
(Source: https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026-w)
Patients with rare disease incur nearly half of all healthcare costs in the U.S.
(Source: https://www.aurorahealthcare.org/research-news/patients-with-rare-diseases-incur-nearly-half-of-all-health-care-costs-in-u.s)
About Lurie Children’s
Ann & Robert H. Lurie Children’s Hospital of Chicago is ranked as one of the nation’s top children’s hospitals by U.S. News & World Report. It is the pediatric training ground for Northwestern University Feinberg School of Medicine. The Division of Genetics, Genomics and Metabolism at Lurie Children’s aims to achieve the highest standards in patient care, research and education. The clinical team provides diagnostic, counseling, and treatment services in multiple areas with direct oversite by highly trained specialists who are recognized nationally and internationally for their expertise. Research at Lurie Children’s is conducted through Stanley Manne Children’s Research Institute.
About the National Organization for Rare Disorders (NORD)
With a 40-year history of advancing care, treatments and policy, the National Organization for Rare Disorders (NORD) is the leading and longest-standing patient advocacy group for the more than 25 million Americans living with a rare disease. NORD, a 501(c)(3) nonprofit, is dedicated to individuals with rare diseases and the organizations that serve them. NORD, along with its more than 330 patient organization members, is committed to improving the health and well-being of people with rare diseases by driving advances in care, research and policy. For more information, please visit https://rarediseases.org/.
END
Lurie Children’s Hospital first in Illinois to be designated as a Rare Disease Center of Excellence by National Organization for Rare Disorders (NORD)
Improving access to care for the 1 in 10 Americans with a rare disease
2023-05-04
ELSE PRESS RELEASES FROM THIS DATE:
Quantum lidar prototype acquires real-time 3D images while fully submerged underwater
2023-05-04
WASHINGTON — For the first time, researchers have demonstrated a prototype lidar system that uses quantum detection technology to acquire 3D images while submerged underwater. The high sensitivity of this system could allow it to capture detailed information even in extremely low-light conditions found underwater.
“This technology could be useful for a wide range of applications,” said research team member Aurora Maccarone, a Royal Academy of Engineering research fellow from Heriot-Watt University in the United Kingdom. “For example, it could be used to inspect underwater installations, such as underwater wind farm cables and the submerged ...
American Geriatrics Society welcomes Donna M. Fick, PhD, GCNS-BC, AGSF, FGSA, FAAN As New President At 2023 Annual Scientific Meeting
2023-05-04
New York (May 3, 2022) — Donna M. Fick, PhD, GCNS-BC, AGSF, FGSA, FAAN will step into the role of President of the American Geriatrics Society (AGS) at the 2023 AGS Annual Scientific meeting which is taking place May 4-6, 2023 (pre-conference day is May 3). An AGS member since 1999 and a member of its Board since 2015, Dr. Fick is committed to working with AGS leaders and members to improve the health, independence, and quality of life of all older people.
“I have always appreciated AGS’ focus, support and advancement of an interprofessional team approach that puts older adults and caregivers at the center, embraces the best evidence ...
Investment in Ontario drug discovery research will help develop new cancer medicines for patients
2023-05-04
May 4, 2023, TORONTO – Ontario research teams investigating new ways to treat cancer are taking the crucial next steps to bring their discoveries to patients thanks to support from the Ontario Institute for Cancer Research (OICR).
OICR announced it is funding five Ontario-based drug discovery projects between $150,000 and $300,000 per project through its Cancer Therapeutics Innovation Pipeline (CTIP) initiative. CTIP supports research into promising molecules that could become the next generation of cancer therapeutics.
This year’s cohort of CTIP projects aims to develop treatments for some of the most devastating cancers, including pancreatic cancer, ovarian cancer, breast cancer ...
Machine learning can support urban planning for energy use
2023-05-04
As Philadelphia strives to meet greenhouse gas emissions goals established in its 2050 Plan, a better understanding of how zoning can play a role in managing building energy use could set the city up for success. Researchers in Drexel University’s College of Engineering are hoping a machine learning model they’ve developed can support these efforts by helping to predict how energy consumption will change as neighborhoods evolve.
In 2017, the city set a goal of becoming carbon neutral by 2050, led in large part by a reduction in greenhouse gas emissions from building energy use – which ...
University of Toronto researchers use generative AI to design novel proteins
2023-05-04
Researchers at the University of Toronto have developed an artificial intelligence system that can create proteins not found in nature using generative diffusion, the same technology behind popular image-creation platforms such as DALL-E and Midjourney.
The system will help advance the field of generative biology, which promises to speed drug development by making the design and testing of entirely new therapeutic proteins more efficient and flexible.
“Our model learns from image representations to generate fully new proteins, at a very high rate,” says Philip ...
St. Jude tool gets more out of multi-omics data
2023-05-04
(MEMPHIS, Tenn. – May 04, 2023) Despite the astounding advances made in understanding the biologic underpinnings of cancer, many cancers are missing obvious genetic drivers. When scientists can’t pinpoint the factors that drive cancer, treating it can be much more difficult. Scientists at St. Jude Children’s Research Hospital hope to solve that problem with an updated way to analyze multi-omic (primarily transcriptomics and proteomics) data. The researchers created a next-generation computational tool to gain new insights from biological data ...
Alternative fuel for string-shaped motors in cells
2023-05-04
Cells have a fascinating feature to neatly organize their interior by using tiny protein machines called molecular motors that generate directed movements. Most of them use a common type of fuel, a kind of chemical energy, called ATP to operate. Now researchers from the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), the Cluster of Excellence Physics of Life (PoL) and the Biotechnology Center (BIOTEC) of the TU Dresden in Dresden, Germany, and the National Centre for Biological Sciences (NCBS) in Bangalore, India, discovered a novel molecular system that uses an alternative chemical energy and employs a novel mechanism ...
How seaweed has been misleading scientists about reef health
2023-05-04
For decades, scientists have looked to seaweed as an indicator of the health of coral reefs lying underneath.
But what if the seaweed was misleading them?
New UBC research reveals it was, and scientists need new ways to determine whether human activity is harming a particular reef.
"This is especially critical today, given that reefs globally are threatened by climate-driven stressors,” said Dr. Sara Cannon, a postdoctoral fellow at the UBC Institute for the Oceans and Fisheries and the study's lead author.
Local species ...
CityU researchers develop an additive to efficiently improve the efficiency and stability of perovskite solar cells
2023-05-04
Perovskite solar cells (PVSCs) are a promising alternative to traditional silicon-based solar cells because of their high power-conversion efficiency and low cost. However, one of the major challenges in their development has been achieving long-term stability. Recently, a research team from City University of Hong Kong (CityU) made a breakthrough by developing an innovative multifunctional and non-volatile additive which can improve the efficiency and stability of perovskite solar cells by modulating perovskite film growth. This simple and effective strategy has great potential for facilitating the commercialisation of PVSCs.
“This type of multifunctional ...
Research reveals longstanding cultural continuity at oldest occupied site in West Africa
2023-05-04
Evidence from West Africa about human evolution remains scarce, but recent research has indicated unique patterns of cultural change in comparison to other regions of the continent. A new article in the journal Nature Ecology and Evolution adds to our understanding with a study of the oldest directly dated archaeological site in West Africa. The site shows technological continuity spanning roughly 140,000 years and offers insights into the ecological stability of the region.
Our species emerged in Africa around 300 thousand years ago and ...
LAST 30 PRESS RELEASES:
New pathway for sensing cold temperatures identified in rice
Study identifies how ovarian cancer protects itself, paves way for improved immunotherapy approach
State policies regulating law enforcement access to prescription drug monitoring program testosterone prescription data
Validation of the Kansas City Cardiomyopathy Questionnaire in patients with tricuspid regurgitation
New study shows combination therapy slows cognitive decline in at-risk populations
Slowing cognitive decline in major depressive disorder and mild cognitive impairment
Autism diagnosis among US children and adults
Researchers identify “sweet spot” for safe surgery after heart attack
Children’s Hospital of Philadelphia researchers identify disparities in healthcare system point of entry for pediatric concussion care
Solar-powered animal cells
ACS research finds lack of health insurance coverage contributes to racial and ethnic disparities in advanced-stage diagnosis of multiple cancers
Exploring the cost and feasibility of battery-electric ships
Scientists say plastic on beaches can now be seen from space
New Starr Cancer Consortium grants awarded to Weill Cornell Medicine researchers
Researchers aim to spark action to address rising homelessness among older people
Comparative metabolism of the humantenirine in liver microsomes from pigs, goats, and humans
Some wildfire suppressants contain heavy metals and could contaminate the environment
McMahon receives NIH grant to help build TTUHSC research capacity
Turning silver to gold: A diacetylene derivative-based metallic luster materials
Faster space communication with record-sensitive receiver
New study shows that university students experienced increased psychological distress during COVID-19, but utilized fewer support services
Camera trap study reveals a “vital sanctuary” for wildlife and endangered species in Cambodia’s Central Cardamom Mountains
Buried Alive: Carbon dioxide release from magma deep beneath ancient volcanoes was a hidden driver of Earth’s past climate
New genetic web tool to help restore climate-resilient marine ecosystems
Three pathways to achieve global climate and sustainable development goals
Giant rats could soon fight illegal wildlife trade by sniffing out elephant tusk and rhino horn
Spin current observations from organic semiconductor side
Alcohol consumption among non-human animals may not be as rare as previously thought, say ecologists
Survey: Dangerous gap in knowledge about pancreatic cancer among adults under age 50
Women entering menopause later in life at greater risk for asthma
[Press-News.org] Lurie Children’s Hospital first in Illinois to be designated as a Rare Disease Center of Excellence by National Organization for Rare Disorders (NORD)Improving access to care for the 1 in 10 Americans with a rare disease